BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 29316729)

  • 1. Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells.
    Kriz V; Korinek V
    Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29316729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-equivalence of Wnt and R-spondin ligands during Lgr5
    Yan KS; Janda CY; Chang J; Zheng GXY; Larkin KA; Luca VC; Chia LA; Mah AT; Han A; Terry JM; Ootani A; Roelf K; Lee M; Yuan J; Li X; Bolen CR; Wilhelmy J; Davies PS; Ueno H; von Furstenberg RJ; Belgrader P; Ziraldo SB; Ordonez H; Henning SJ; Wong MH; Snyder MP; Weissman IL; Hsueh AJ; Mikkelsen TS; Garcia KC; Kuo CJ
    Nature; 2017 May; 545(7653):238-242. PubMed ID: 28467820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling in adult intestinal stem cells and cancer.
    Krausova M; Korinek V
    Cell Signal; 2014 Mar; 26(3):570-9. PubMed ID: 24308963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ε.
    Xu F; Wang YL; Chang JJ; Du SC; Diao L; Jiang N; Wang HJ; Ma D; Zhang J
    Biochem J; 2014 Feb; 458(1):159-69. PubMed ID: 24180524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.
    Imajo M; Miyatake K; Iimura A; Miyamoto A; Nishida E
    EMBO J; 2012 Mar; 31(5):1109-22. PubMed ID: 22234184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo pathway regulates Wnt/beta-catenin signaling.
    Varelas X; Miller BW; Sopko R; Song S; Gregorieff A; Fellouse FA; Sakuma R; Pawson T; Hunziker W; McNeill H; Wrana JL; Attisano L
    Dev Cell; 2010 Apr; 18(4):579-91. PubMed ID: 20412773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cftr Modulates Wnt/β-Catenin Signaling and Stem Cell Proliferation in Murine Intestine.
    Strubberg AM; Liu J; Walker NM; Stefanski CD; MacLeod RJ; Magness ST; Clarke LL
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):253-271. PubMed ID: 29675451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential influence of YAP1 and TAZ on differentiation of intestinal epithelial cell: A review.
    Fallah S; Beaulieu JF
    Anat Rec (Hoboken); 2023 May; 306(5):1054-1061. PubMed ID: 35648375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue.
    Li N; Lu N; Xie C
    FEBS J; 2019 Oct; 286(19):3745-3756. PubMed ID: 31342636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
    Xu F; Zhang J; Ma D
    Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo pathway in colorectal cancer.
    Wierzbicki PM; Rybarczyk A
    Folia Histochem Cytobiol; 2015; 53(2):105-19. PubMed ID: 26160682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration.
    Chen X; Li Y; Luo J; Hou N
    Front Physiol; 2020; 11():389. PubMed ID: 32390875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders.
    Sileo P; Simonin C; Melnyk P; Chartier-Harlin MC; Cotelle P
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.
    Mui CW; Chan WN; Chen B; Cheung AH; Yu J; Lo KW; Ke H; Kang W; To KF
    Int J Cancer; 2023 Feb; 152(4):558-571. PubMed ID: 35983734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TAZ as mediator of Wnt signaling.
    Azzolin L; Zanconato F; Bresolin S; Forcato M; Basso G; Bicciato S; Cordenonsi M; Piccolo S
    Cell; 2012 Dec; 151(7):1443-56. PubMed ID: 23245942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXKs promote Wnt/β-catenin signaling by translocating DVL into the nucleus.
    Wang W; Li X; Lee M; Jun S; Aziz KE; Feng L; Tran MK; Li N; McCrea PD; Park JI; Chen J
    Dev Cell; 2015 Mar; 32(6):707-18. PubMed ID: 25805136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients.
    Abduch RH; Carolina Bueno A; Leal LF; Cavalcanti MM; Gomes DC; Brandalise SR; Masterallo MJ; Yunes JA; Martinelli CE; Tone LG; Tucci S; Molina CA; Ramalho FS; Moreira AC; Cardinalli IA; Scrideli CA; Ramalho LN; de Castro M; Antonini SR
    Oncotarget; 2016 Dec; 7(51):84634-84644. PubMed ID: 27705928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology.
    Chen X; Yuan W; Li Y; Luo J; Hou N
    Int J Biol Sci; 2020; 16(13):2454-2463. PubMed ID: 32760212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.